SLS · SELLAS Life Sciences Group, Inc.
$14.09
-1.37 (-8.86%)
At close · Aug 24
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Codification ("ASC") 205-40, Presentation of Financial Statements - Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the consolidated financial statements are issued. The Company expects its cash and cash equivalents will be sufficient to fund its current planned operations for at least the next twelve months from the date of issuance of these consolidated financial statements”View the 10-Q filed Aug 11, 2026
Market Cap
$3.12B
Shares
201.95M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
175 filings
173 filers
Visit website
Investor relations